You are here: Home » News-CM » Companies » Results
Business Standard

ERIS Lifesciences standalone net profit rises 8.99% in the September 2019 quarter

Capital Market 

Sales rise 13.22% to Rs 268.42 crore

Net profit of ERIS Lifesciences rose 8.99% to Rs 91.53 crore in the quarter ended September 2019 as against Rs 83.98 crore during the previous quarter ended September 2018. Sales rose 13.22% to Rs 268.42 crore in the quarter ended September 2019 as against Rs 237.07 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales268.42237.07 13 OPM %39.9440.95 -PBDT111.7097.07 15 PBT101.3289.99 13 NP91.5383.98 9

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, November 08 2019. 11:22 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU